Entera Bio Ltd.
ENTX | NASDAQ
$2.98
+$0.02 (+0.68%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 42K | 181K | n/a | 134K | 571K | 365K |
Cost of Revenue | 42K | 172K | 56K | 165K | 373K | 300K |
Gross Profit | n/a | 9K | -56K | -31K | 198K | 65K |
Operating Income | -11.53M | -9.59M | -8.94M | -13.07M | -12.22M | -11.17M |
Interest Income | n/a | 58K | 31K | 83K | n/a | n/a |
Pretax Income | -11.44M | -9.53M | -8.86M | -12.93M | -12.25M | -11.2M |
Net Income | -11.44M | -9.54M | -8.89M | -13.07M | -12.19M | -11.22M |
Selling & General & Admin | 5.53M | 5.1M | 4.43M | 7.25M | 5.69M | 4.85M |
Research & Development | 6M | 4.5M | 4.45M | 5.78M | 6.77M | 6.38M |
Other Expenses | n/a | n/a | n/a | n/a | -46K | n/a |
Operating Expenses | 11.53M | 9.59M | 8.88M | 13.04M | 12.42M | 11.23M |
Interest Expense | n/a | n/a | n/a | n/a | 29K | 28K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.57M | 9.77M | 8.94M | 13.2M | 12.79M | 11.53M |
Income Tax Expense | n/a | 14K | 29K | 137K | -59K | 20K |
Shares Outstanding (Basic) | 46.19M | 37.65M | 29.01M | 28.81M | 26.13M | 18.42M |
Shares Outstanding (Diluted) | 46.19M | 37.65M | 29.01M | 28.81M | 26.13M | 18.42M |
EPS (Basic) | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | -0.54 |
EPS (Diluted) | -0.25 | -0.25 | -0.31 | -0.45 | -0.47 | -0.54 |
EBITDA | -11.41M | -9.48M | -8.8M | -12.87M | -12.16M | -11.11M |
EBIT | -11.44M | -9.53M | -8.86M | -12.93M | -12.22M | -11.17M |
Depreciation & Amortization | 30K | 46K | 56K | 64K | 53K | 63K |
Add to Watchlist
Select watchlists to add or remove ENTX